South & Central America Custom Antibody Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The custom antibody services market in South and Central America is projected to grow significantly, reaching approximately USD 49.87 million by 2031, up from USD 23.73 million in 2023, with an estimated compound annual growth rate (CAGR) of 9.7% from 2023 to 2031.

Executive Summary and Market Analysis

The expansion of the custom antibody services market in South and Central America is primarily fueled by increased investments in biomedical research, a rise in chronic disease prevalence, and a growing demand for targeted therapies. Brazil and Argentina are becoming pivotal players in this market due to enhancements in research infrastructure and increased healthcare expenditures. Academic institutions and biotechnology companies are increasingly outsourcing antibody development to specialized service providers to expedite drug discovery and diagnostic processes. Despite facing challenges such as limited funding and regulatory obstacles, the market is expected to experience steady growth, supported by technological advancements and international collaborations.

Market Segmentation Analysis

The South and Central America custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

Product Type: The market is divided into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.
Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading in market share in 2023.
Application: The applications include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the dominant application in 2023.
Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.
Source: This includes chicken, rabbits, rats, guinea pigs, and mouse or humanized mice, with the latter holding the largest share in 2023. This segment further includes monoclonal antibody platforms, bispecific antibody discovery platforms, and others.
End User: The end users are categorized into the life sciences industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life sciences industry leading in market share in 2023.

Market Outlook

Recombinant antibody engineering presents vast opportunities for drug developers and researchers to create specific molecules tailored for particular diseases. Many developers are leveraging AI technologies to predict and analyze potential therapeutics from antibody sequences, enhancing the efficiency of drug development. For example, Foundation Medicine utilizes next-generation sequencing technology to create genomic profiling assays that help match patients with targeted therapies and clinical trials. Similarly, the Medicines Discovery Catapult is employing in-silico methods to identify new cancer treatment molecules, showcasing the integration of AI in drug discovery.

Country Insights

The market comprises Brazil, Argentina, and other regions in South and Central America, with Brazil holding the largest market share in 2023. The aging population in Brazil is contributing to a rise in chronic diseases. According to the Pan American Health Organization, over 30 million Brazilians are aged 60 and above, a figure expected to rise to nearly 50 million by 2030. This demographic shift is associated with increased incidences of chronic conditions, making custom antibodies vital for targeted diagnostics and treatments.

Brazil has seen significant regulatory support for antibody research, with initiatives such as the authorization of Sorrento Therapeutics for clinical trials involving monoclonal antibodies for COVID-19. Additionally, GenScript's approval for a neutralization antibody detection kit and collaborations for developing biosimilars indicate a robust environment for biopharmaceutical research. These developments, along with ongoing improvements in healthcare infrastructure and diagnostic laboratories, are anticipated to further stimulate market growth.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., Kaneka Eurogentec S.A., Fortis Life Sciences, Precision Antibody, Biocytogen Pharmaceuticals, Abgenex, Creative Biolabs, Agilent Technologies, Bioklone, and Scantibodies Laboratory, Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Product Code: BMIRE00032165

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Custom Antibody Services Market Landscape

4.1 Overview
4.2 PEST Analysis

5. South & Central America Custom Antibody Services Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Rising Approvals of Biosimilars
5.2 Market Restraints
- 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
5.3 Market Opportunities
- 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
5.4 Future Trends
- 5.4.1 Technological Advancements Using Recombinant Antibodies
5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - South & Central America Analysis

6.1 South & Central America Custom Antibody Services Market Revenue (US$ Million), 2021-2031
6.2 South & Central America Custom Antibody Services Market Forecast Analysis

7. South & Central America Custom Antibody Services Market Analysis - by End User

7.1 Life Science Industry
- 7.1.1 Overview
- 7.1.2 Life Science Industry: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Pharmaceutical and Biotech Companies
- 7.2.1 Overview
- 7.2.2 Pharmaceutical and Biotech Companies: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Academic and Research Institutes
- 7.3.1 Overview
- 7.3.2 Academic and Research Institutes: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Contract Research Organizations
- 7.4.1 Overview
- 7.4.2 Contract Research Organizations: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Custom Antibody Services Market Analysis - by Disease Indication

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Infectious Diseases
- 8.2.1 Overview
- 8.2.2 Infectious Diseases: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Immunology: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cardiovascular Diseases
- 8.4.1 Overview
- 8.4.2 Cardiovascular Diseases: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Custom Antibody Services Market Analysis - by Source

9.1 Chicken
- 9.1.1 Overview
- 9.1.2 Chicken: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Rabbits
- 9.2.1 Overview
- 9.2.2 Rabbits: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Rats
- 9.3.1 Overview
- 9.3.2 Rats: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Guinea Pigs
- 9.4.1 Overview
- 9.4.2 Guinea Pigs: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Mouse or Humanized Mice
- 9.5.1 Overview
- 9.5.2 Mouse or Humanized Mice: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

10.1 Monoclonal Antibody Platform
- 10.1.1 Monoclonal Antibody Platform: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2 BsAb Discovery Platform
- 10.2.1 BsAb Discovery Platform: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Bispecific ADC Platform
- 10.3.1 Bispecific ADC Platform: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4 TCR-Mimic Antibody Platform
- 10.4.1 TCR-Mimic Antibody Platform: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Anti-GPCR Antibody Technology Platform
- 10.5.1 Anti-GPCR Antibody Technology Platform: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6 Others
- 10.6.1 Others: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. South & Central America Custom Antibody Services Market Analysis - by Application

11.1 Immunohistochemistry (IHC)
- 11.1.1 Overview
- 11.1.2 Immunohistochemistry (IHC): South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2 Western Blot and IP
- 11.2.1 Overview
- 11.2.2 Western Blot and IP: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3 ELISA
- 11.3.1 Overview
- 11.3.2 ELISA: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4 Fluorescence-activated cell sorting (FACS)
- 11.4.1 Overview
- 11.4.2 Fluorescence-activated cell sorting (FACS): South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5 Mass Spectrometry
- 11.5.1 Overview
- 11.5.2 Mass Spectrometry: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. South & Central America Custom Antibody Services Market Analysis - by Service Type

12.1 Antibody Discovery and Development
- 12.1.1 Overview
- 12.1.2 Antibody Discovery and Development: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2 Antibody Production Services
- 12.2.1 Overview
- 12.2.2 Antibody Production Services: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3 Others
- 12.3.1 Overview
- 12.3.2 Others: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. South & Central America Custom Antibody Services Market Analysis - by Product Type

13.1 Monoclonal
- 13.1.1 Overview
- 13.1.2 Monoclonal: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.2 Polyclonal hybridoma
- 13.2.1 Overview
- 13.2.2 Polyclonal hybridoma: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.3 Recombinant antibody
- 13.3.1 Overview
- 13.3.2 Recombinant antibody: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.4 Others
- 13.4.1 Overview
- 13.4.2 Others: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. South & Central America Custom Antibody Services Market - Country Analysis

14.1 South & Central America
- 14.1.1 South & Central America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.1 South & Central America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.2 Brazil: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.2.1 Brazil: South & Central America Custom Antibody Services Market Share - by End User
    - 14.1.1.2.2 Brazil: South & Central America Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.2.3 Brazil: South & Central America Custom Antibody Services Market Share - by Source
    - 14.1.1.2.4 Brazil: South & Central America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.2.5 Brazil: South & Central America Custom Antibody Services Market Share - by Application
    - 14.1.1.2.6 Brazil: South & Central America Custom Antibody Services Market Share - by Service Type
    - 14.1.1.2.7 Brazil: South & Central America Custom Antibody Services Market Share - by Product Type
  - 14.1.1.3 Argentina: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.3.1 Argentina: South & Central America Custom Antibody Services Market Share - by End User
    - 14.1.1.3.2 Argentina: South & Central America Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.3.3 Argentina: South & Central America Custom Antibody Services Market Share - by Source
    - 14.1.1.3.4 Argentina: South & Central America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.3.5 Argentina: South & Central America Custom Antibody Services Market Share - by Application
    - 14.1.1.3.6 Argentina: South & Central America Custom Antibody Services Market Share - by Service Type
    - 14.1.1.3.7 Argentina: South & Central America Custom Antibody Services Market Share - by Product Type
  - 14.1.1.4 Rest of South & Central America: South & Central America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.4.1 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by End User
    - 14.1.1.4.2 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.4.3 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by Source
    - 14.1.1.4.4 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.4.5 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by Application
    - 14.1.1.4.6 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by Service Type
    - 14.1.1.4.7 Rest of South & Central America: South & Central America Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

15.1 Overview
15.2 Growth Strategies in Custom Antibody Services Market
15.3 Organic Growth Strategies
- 15.3.1 Overview
15.4 Inorganic Growth Strategies
- 15.4.1 Overview

16. Company Profiles

16.1 Thermo Fisher Scientific Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Sino Biological Inc.
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 GenScript Biotech Corporation
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Biochain Incorporated
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 R&D Systems, Inc
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Kaneka Eurogentec S.A.
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Fortis Life Sciences
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Abgenex
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Creative Biolabs Inc
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Agilent Technologies Inc
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments
16.13 Bioklone
- 16.13.1 Key Facts
- 16.13.2 Business Description
- 16.13.3 Products and Services
- 16.13.4 Financial Overview
- 16.13.5 SWOT Analysis
- 16.13.6 Key Developments
16.14 Scantibodies Laboratory, Inc.
- 16.14.1 Key Facts
- 16.14.2 Business Description
- 16.14.3 Products and Services
- 16.14.4 Financial Overview
- 16.14.5 SWOT Analysis
- 16.14.6 Key Developments

17. Appendix

17.1 About The Insight Partners
17.2 Glossary of Terms